ERK2 monoclonal antibody

CAT:
384-MB66953-01
Size:
50 µL
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
ERK2 monoclonal antibody - image 1

ERK2 monoclonal antibody

  • Background:

    Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs, such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli, including mitogens, growth factors, and cytokines , and research investigators consider it an important target in the diagnosis and treatment of cancer . Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK) . Multiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as Mos and Tpl2/COT. MEK1 and MEK2 are the primary MAPKKs in this pathway . MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK and the transcription factor Elk-1 . p44/42 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs , along with MEK inhibitors, such as U0126 and PD98059.
  • Structure Composition:

    Mouse IgG1 kappa. Liquid in PBS, pH 7.3, 30% glycerol, and 0.01% sodium azide.
  • Product Name Alternative:

    ERK2; PRKM1; PRKM2; Mitogen-activated protein kinase 1; MAP kinase 1; MAPK 1; ERT1; Extracellular signal-regulated kinase 2; ERK-2; MAP kinase isoform p42; p42-MAPK; Mitogen-activated protein kinase 2; MAP kinase 2; MAPK 2
  • Swiss Prot:

    P28482
  • Reactivity:

    Human, Mouse
  • Immunogen:

    KLH-conjugated synthetic peptide encompassing a sequence within the center region of human ERK2. The exact sequence is proprietary.
  • Conjugation:

    Unconjugated
  • Related Pathways:

    Tumor Angiogenesis, Regulation of Apoptosis, ESC Pluripotency and Differentiation Signaling Pathway, ErbB HER Signaling, G Protein-coupled Receptors Signaling to MAPK Erk, MAPK Erk in Growth and Differentiation Pathway, Jak Stat : IL-6 Receptor Signaling, Inhibition of Apoptosis, Insulin &Glucose Signaling, Regulation of Microtubule Dynamics, Mitochondrial Control of Apoptosis, T cell receptor signaling, TGFβ Smad signaling, Translational Contral elF4 and p70 S6 Kinase, Warburg Effect, MTOR signaling.
  • Applications:

    WB
  • Dilution:

    WB (1/500 - 1/1000)
  • Purity:

    This antibody is purified through a protein G column.
  • Modification:

    Unmodification
  • Molecular Weight:

    ~ 37 kDa
  • Storage Conditions:

    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
  • Notes:

    For research use only, not for use in diagnostic procedure.
  • Specificity:

    Recognizes endogenous levels of ERK2 protein.
  • Applications Notes:

    Western blot analysis of ERK2 expression in Hela (A), HelaMAPK1Knock out (B) whole cell lysates.
  • Host or Source:

    Mouse
  • CAS Number:

    9007-83-4